ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $0 | – | 0 | – | 0.00% | – |
| Q1 2021 | $0 | – | 0 | – | 0.00% | – |
| Q4 2020 | $0 | – | 0 | – | 0.00% | – |
| Q3 2020 | $0 | – | 0 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
| Q1 2020 | $0 | – | 0 | – | 0.00% | – |
| Q4 2019 | $0 | – | 0 | – | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q4 2018 | $1,000 | -50.0% | 519 | -16.2% | 0.00% | – |
| Q3 2018 | $2,000 | 0.0% | 619 | 0.0% | 0.00% | – |
| Q2 2018 | $2,000 | – | 619 | +519.0% | 0.00% | – |
| Q1 2018 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | -100.0% | 100 | -84.1% | 0.00% | – |
| Q3 2017 | $3,000 | -93.0% | 630 | -93.2% | 0.00% | -100.0% |
| Q2 2017 | $43,000 | +1333.3% | 9,290 | +1374.6% | 0.00% | – |
| Q1 2017 | $3,000 | 0.0% | 630 | 0.0% | 0.00% | – |
| Q4 2016 | $3,000 | -25.0% | 630 | +18.9% | 0.00% | – |
| Q3 2016 | $4,000 | 0.0% | 530 | 0.0% | 0.00% | – |
| Q2 2016 | $4,000 | 0.0% | 530 | +60.6% | 0.00% | – |
| Q4 2015 | $4,000 | – | 330 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 12,033,220 | $92,896,000 | 11.87% |
| RTW INVESTMENTS, LP | 2,558,859 | $19,754,000 | 7.17% |
| TURNER INVESTMENTS LLC | 859,560 | $6,636,000 | 1.80% |
| DAFNA Capital Management LLC | 236,500 | $1,826,000 | 1.58% |
| Ghost Tree Capital, LLC | 250,000 | $1,930,000 | 1.09% |
| Orbimed Advisors | 11,519,700 | $88,932,000 | 0.94% |
| Rock Springs Capital Management LP | 1,220,000 | $9,418,000 | 0.79% |
| Opus Point Partners Management, LLC | 99,000 | $764,000 | 0.59% |
| Bellevue Group AG | 420,000 | $3,242,000 | 0.59% |
| Cormorant Asset Management, LP | 500,000 | $3,860,000 | 0.58% |